Susquehanna International Group’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$344K Buy
304,812
+147,168
+93% +$166K ﹤0.01% 4849
2025
Q1
$230K Buy
157,644
+4,042
+3% +$5.9K ﹤0.01% 5363
2024
Q4
$327K Buy
153,602
+71,146
+86% +$152K ﹤0.01% 4644
2024
Q3
$231K Sell
82,456
-5,286
-6% -$14.8K ﹤0.01% 4635
2024
Q2
$204K Sell
87,742
-8,064
-8% -$18.8K ﹤0.01% 4710
2024
Q1
$428K Sell
95,806
-153,505
-62% -$686K ﹤0.01% 3738
2023
Q4
$800K Sell
249,311
-77,055
-24% -$247K ﹤0.01% 3173
2023
Q3
$1.03M Sell
326,366
-11,610
-3% -$36.8K ﹤0.01% 2530
2023
Q2
$1.68M Sell
337,976
-161,958
-32% -$805K ﹤0.01% 2097
2023
Q1
$2.47M Buy
499,934
+434,954
+669% +$2.15M ﹤0.01% 1743
2022
Q4
$409K Sell
64,980
-138,239
-68% -$870K ﹤0.01% 3479
2022
Q3
$2.2M Buy
203,219
+41,307
+26% +$446K ﹤0.01% 1576
2022
Q2
$1.85M Sell
161,912
-17,108
-10% -$195K ﹤0.01% 1752
2022
Q1
$1.63M Sell
179,020
-65,309
-27% -$595K ﹤0.01% 2241
2021
Q4
$3.65M Buy
244,329
+142,706
+140% +$2.13M ﹤0.01% 1438
2021
Q3
$2.61M Buy
101,623
+15,997
+19% +$411K ﹤0.01% 1692
2021
Q2
$2.23M Sell
85,626
-68,624
-44% -$1.79M ﹤0.01% 1961
2021
Q1
$5.45M Buy
154,250
+92,410
+149% +$3.26M ﹤0.01% 1175
2020
Q4
$1.56M Buy
61,840
+40,388
+188% +$1.02M ﹤0.01% 2009
2020
Q3
$809K Sell
21,452
-2,761
-11% -$104K ﹤0.01% 2497
2020
Q2
$1.04M Sell
24,213
-23,710
-49% -$1.02M ﹤0.01% 2118
2020
Q1
$932K Buy
+47,923
New +$932K ﹤0.01% 2131
2019
Q4
Sell
-30,447
Closed -$830K 3964
2019
Q3
$830K Sell
30,447
-11,234
-27% -$306K ﹤0.01% 2252
2019
Q2
$1.12M Buy
+41,681
New +$1.12M ﹤0.01% 1898
2019
Q1
Hold
0
2990
2018
Q4
Hold
0
3617